WO2018155974A1 - 블루라이트 필터링 및 자외선 차단 화장료 조성물 - Google Patents
블루라이트 필터링 및 자외선 차단 화장료 조성물 Download PDFInfo
- Publication number
- WO2018155974A1 WO2018155974A1 PCT/KR2018/002319 KR2018002319W WO2018155974A1 WO 2018155974 A1 WO2018155974 A1 WO 2018155974A1 KR 2018002319 W KR2018002319 W KR 2018002319W WO 2018155974 A1 WO2018155974 A1 WO 2018155974A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic composition
- visible light
- blocking
- hydrophobic
- less
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 167
- 239000002537 cosmetic Substances 0.000 title claims abstract description 82
- 230000000903 blocking effect Effects 0.000 title claims abstract description 50
- 238000001914 filtration Methods 0.000 title abstract description 3
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000008346 aqueous phase Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000002981 blocking agent Substances 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims description 55
- 238000009472 formulation Methods 0.000 claims description 54
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 38
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000012071 phase Substances 0.000 claims description 32
- 239000000516 sunscreening agent Substances 0.000 claims description 30
- 239000000839 emulsion Substances 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 26
- 230000000475 sunscreen effect Effects 0.000 claims description 26
- -1 BaSO 3 ) Chemical compound 0.000 claims description 24
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002562 thickening agent Substances 0.000 claims description 21
- 229920002545 silicone oil Polymers 0.000 claims description 19
- 239000011787 zinc oxide Substances 0.000 claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000004408 titanium dioxide Substances 0.000 claims description 16
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 14
- 229930195712 glutamate Natural products 0.000 claims description 14
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 13
- 229910019142 PO4 Inorganic materials 0.000 claims description 12
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 12
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 12
- 239000010452 phosphate Substances 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 10
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical group [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 238000004381 surface treatment Methods 0.000 claims description 5
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
- 239000000454 talc Substances 0.000 claims description 4
- 229910052623 talc Inorganic materials 0.000 claims description 4
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 claims description 3
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000010445 mica Substances 0.000 claims description 3
- 229910052618 mica group Inorganic materials 0.000 claims description 3
- 239000007764 o/w emulsion Substances 0.000 claims description 3
- 229960001679 octinoxate Drugs 0.000 claims description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- WAYZRKGVWCXYPB-UHFFFAOYSA-N 1-silyloctan-1-one Chemical compound CCCCCCCC([SiH3])=O WAYZRKGVWCXYPB-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 2
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229920003086 cellulose ether Polymers 0.000 claims description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 claims description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 claims description 2
- 229940079784 disodium stearoyl glutamate Drugs 0.000 claims description 2
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 claims description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 2
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- PWZDAQKVUDZPRI-LMOVPXPDSA-M sodium;(4s)-4-amino-5-oxo-5-tetradecoxypentanoate Chemical compound [Na+].CCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O PWZDAQKVUDZPRI-LMOVPXPDSA-M 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 240000008881 Oenanthe javanica Species 0.000 claims 1
- 238000011161 development Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 23
- 239000000463 material Substances 0.000 description 18
- 230000009931 harmful effect Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 238000012937 correction Methods 0.000 description 11
- 235000021317 phosphate Nutrition 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000006210 lotion Substances 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000049 pigment Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000006750 UV protection Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 239000006103 coloring component Substances 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 2
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- PHSXXZQAGYUASL-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecyl hydrogen phosphate Chemical compound CC(C)CCCCCCCCCCCCCCCOP(O)(=O)OCC(O)CO PHSXXZQAGYUASL-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940117927 ethylene oxide Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Definitions
- OIL-DISPERSIBILITY refers to a property or degree that is well dispersed in an oil or oil component, and is a concept included in hydrophobicity.
- WATER-DISPERSIBILITY refers to a property or degree that is well dispersed in water or a water-soluble substance, and is a concept included in hydrophilicity.
- coloring component refers to pigments, pigments, and other materials having the ability to produce color. It may include a “pigment”, preferably a pigment component that can be used as a raw material for cosmetics.
- Coloring components are titanium dioxide, micro titanium oxide (Micro TiO 2 ), zinc oxide, zinc oxide, micro zinc oxide (Micro ZnO), iron oxide (iron oxide, FeO (II), Fe 2 O 3 ( III), Fe 3 O 4 (IV)), aluminum oxide (alumina, Al 2 O 3 ), barium sulfate (barium sulfate, BaSO 3 ), PMMA (polymethylmethacrylate), silica, nylon, polyurethane, ultra It may be one or more selected from the group consisting of marine, pearl, synthetic mica, mica, talc, kaolin, sericite and boron nitride, but is not limited thereto.
- anionic surfactant means that the portion of the surfactant that is ionized when dissolved in water becomes anion.
- Surfactants include nonionic surfactants (surfactants that do not dissociate into aqueous solutions because they do not have an ionizing atomic group in their molecules), and cationic surfactants (surfactants that become valence cations that dissolve in water and dissociate into ions). ), Anionic surfactants, and amphoteric surfactants (surfactants having both a cationic group and an anionic group in the same molecule).
- phosphate surfactant refers to a surfactant comprising a chemical structural phosphate
- glutamate surfactant refers to a surfactant comprising a chemical structural glutamate
- carbamate surfactant refers to a chemical structural carbamate Means a surfactant containing.
- the oil phase including a sunscreen and silicone oil;
- An aqueous phase including at least one thickener selected from the group consisting of phosphate surfactants, glutamate surfactants and carbamate surfactants;
- a hydrophobic visible light blocking agent homogeneously dispersed for example, in the form of emulsion particles
- the particle size of the dispersed emulsion may have an average diameter of 0.1 to 20 ⁇ m as measured by an optical microscope.
- the average diameter is 0.1 ⁇ m, 0.5 ⁇ m, 0.8 ⁇ m, 1 ⁇ m, 1.2 ⁇ m, 1.5 ⁇ m, 2 ⁇ m, 3 ⁇ m, 4 ⁇ m, 5 ⁇ m, 7 or at least 9 ⁇ m, at least 9 ⁇ m, at least 12 ⁇ m, at least 15 ⁇ m, or at least 18 ⁇ m.
- the average diameter may be 20 ⁇ m or less, 18 ⁇ m or less, 15 ⁇ m or less, 13 ⁇ m or less, 10 ⁇ m or less, 8 ⁇ m or less, 6 ⁇ m or less, 4 ⁇ m or less, 2 ⁇ m or less, 1 ⁇ m or less, 0.8 ⁇ m or less, 0.5 ⁇ m or less, or 0.2 ⁇ m or less.
- the average diameter may be 1 to 5 ⁇ m.
- the sunscreen may be at least one of an organic sunscreen and an inorganic sunscreen.
- the silicone oil may be at least one selected from the group consisting of silicone oils including cyclomethicone, dimethicone, cyclopentasiloxane, and cyclohexasiloxane.
- the silicone oil may be at least one of cyclopentasiloxane and cyclohexasiloxane.
- the hydrocarbon-based oil including squalane or mineral oil in place of the silicone oil; Ester-based oils including isopropyl palmitate, 2-octyldodecyl myristate, isopropyl mysteryte or butyloctyl salicylate; And vegetable oils, including castor oil, olive oil or jojoba oil.
- Surfactants that can be used in the composition according to an aspect of the present invention include anionic surfactants such as sulfates, sulfosuccinates, sacosinates, phosphates, isethionates, glutamate, taurates, and the like.
- the hydrophilic group may have a phosphate, sulfate, glutamate or citrate, etc., and the counterion may have sodium, potassium or ammonium, and the hydrophobic group generally has a fatty alkyl group between C2 and C24 Surfactants can be used.
- the surfactant may be a phosphate surfactant or glutamate surfactant, and instead of the anionic surfactant, a carbamate surfactant (surfactant comprising carbamate in chemical structure, preferably inulin lauryl carbamate) May be used.
- a carbamate surfactant surfactant comprising carbamate in chemical structure, preferably inulin lauryl carbamate
- potassium cetylphosphate, aluminum isostearyl glyceryl phosphate, sodium lauryl sulfate, sodium stearoyl glutamate, and inulin lauryl carbamate It may be one or more, more preferably potassium cetylphosphate.
- the cosmetic composition according to one aspect of the present invention may further contain one or more emulsifiers in addition to the above components.
- emulsifiers for example, Lecithin, Hydrogenated Lecithin, Lysolecithin, Hydrogenated Dryosolecithin, Polysorbate 60, Fiji-40 Stearate, Octyldodeces-25, Ceteares-20, Fiji-20 Glycerin
- It may further contain one or more emulsifiers selected from the group consisting of rilisisostearate, polyglyceryl-3 methylglucose distearate, cetearylglucoside, polyglyceryl-10 stearate, and the like, but is not limited thereto. It is not.
- the emulsifier further contained may contain 0.01 to 10 wt% based on the total weight of the cosmetic composition. If it is less than 0.01% by weight it is difficult to achieve the emulsification purpose, if it exceeds 10% by weight it may irritate the skin.
- any one or more phases of the water phase and oil phase may further comprise a thickener.
- a thickener for example, sodium acrylate copolymers, crosslinked or uncrosslinked acrylic acid polymers, in particular polyacrylic acids, cellulose derivatives crosslinked with polyfunctional functional groups (such as methylcellulose, hydroxymethylcellulose, hydroxyethyl cellulose, hydroxypropyl methylcellulose, carboxy Methyl cellulose, carboxymethyl cellulose), sodium salt of cellulose derivative, cetylstearyl alcohol, oxyethylenated cetylstearyl alcohol containing ethylene oxide, guar gum, xanthan gum and combinations thereof. have.
- the thickener may be contained in 0.001 to 20.0% by weight in the total composition.
- the hydrophobic visible light blocker may be an inorganic powder surface-treated hydrophobic.
- the surface treatment is dimethicone, methicone, caprylyl silane with substituents introduced, lauroyl lysine, disodium stearoyl glutamate, sodium myristyl glutamate, silica, alumina, And it may be treated with one or more selected from the group consisting of aluminum hydroxide.
- the harmful light blocking effect can be obtained and the skin tone correction effect can be achieved.
- the hydrophobic visible light blocker or the hydrophobic surface-treated inorganic powder may be titanium dioxide coated with aluminum hydroxide and triethoxycaprylylsilane.
- the content of the hydrophobic visible light blocker may be 0.5 to 5% by weight based on the total weight of the composition. If it is less than 0.5% by weight, the coloring or visible light blocking effect is weak, and if it exceeds 5% by weight, the dispersion in the formulation is not smooth, and the formulation stability is significantly lowered.
- the content of the hydrophobic visible light blocker is 0.5% by weight, 0.8% by weight, 1% by weight, 1.2% by weight, 1.4% by weight, 1.6% by weight, 1.8% by weight, 2% by weight, 2.2% by weight Or at least 2.4 wt%, at least 2.6 wt%, at least 2.8 wt%, at least 3 wt%, at least 3.5 wt%, at least 4 wt%, at least 4.5 wt%, or at least 4.8 wt%.
- the content is 5 wt% or less, 4.8 wt% or less, 4.5 wt% or less, 4 wt% or less, 3.5 wt% or less, 3 wt% or less, 2.8 wt% or less, 2.6 wt% or less, 2.4 wt% or less, It may be 2.2 wt% or less, 2 wt% or less, 1.8 wt% or less, 1.6 wt% or less, 1.4 wt% or less, 1.2 wt% or less, 1 wt% or less, 0.8 wt% or less, or 0.6 wt% or less. Preferably at least 1% by weight may be less than 3% by weight.
- the content of the anionic surfactant is 2 wt% or less, 1.8 wt% or less, 1.6 wt% or less, 1.5 wt% or less, 1.4 wt% or less, 1.2 wt% or less, 1.0 wt% or less, 0.8 wt% or less, and 0.6 wt% or less. It may be up to weight percent, or up to 0.55 weight percent.
- the visible light may have a wavelength of 380 ⁇ 800 nm.
- the light source may be at least one of violet light having a wavelength of 380 to 430 nm, and blue light having a wavelength of 430 to 500 nm.
- the cosmetic composition may be to block 60% or more of violet light.
- the cosmetic composition comprises at least 60%, at least 65%, at least 68%, at least 70%, at least 75%, at least 78%, at least 80%, at least 85%, at least 90%, at least 95%, or 97% of violet light. It may be an abnormal blocking.
- the composition may contain up to 98%, up to 95%, up to 90%, up to 85%, up to 80%, up to 78%, up to 75%, up to 70%, up to 68%, up to 65%, or up to 63% of the violet light. It may be to block below.
- the cosmetic composition may be to block 35% or more blue light.
- the composition comprises at least 35%, at least 36%, at least 38%, at least 40%, at least 42%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, or at least 68% of the blue light. It may be blocking.
- the composition may contain 70% or less, 68% or less, 65% or less, 60% or less, 55% or less, 50% or less, 45% or less, 42% or less, 40% or less, 38% or less, or 36% blue light. It may be blocking below%.
- the cosmetic composition may be an emulsion or a cream formulation.
- the cosmetic composition may be an oil-in-water (O / W) emulsion formulation.
- O / W oil-in-water
- the present specification may be applied to other formulations, but may particularly relate to an O / W emulsion composition and a formulation stabilization method thereof.
- O / W emulsions it is very difficult to disperse the hydrophobic visible light blocking agent (for example, titanium dioxide surface-treated with hydrophobic material, zinc oxide surface-treated with hydrophobic material, etc.), and even if dispersed, O / W formulation stability Although very difficult to maintain, the present invention solves such a challenge in one aspect.
- the cosmetic composition may be a liquid or cream formulation.
- the cosmetic composition may be that the stability of the formulation is maintained for more than 4 weeks at -30 °C to 60 °C.
- the temperature is -30 ° C or more, -20 ° C or more, -10 ° C or more, -5 ° C or more, 0 ° C or more, 5 ° C or more, 10 ° C or more, 15 ° C or more, 20 ° C or more, 25 ° C
- the said temperature is 60 degrees C or less, 55 degrees C or less, 50 degrees C or less, 45 degrees C or less, 40 degrees C or less, 35 degrees C or less, 30 degrees C or less, 25 degrees C or less, 20 degrees C or less, 15 degrees C or less, 10 degrees C or less, 5 Or less, or less than or equal to 0 ° C, or less than or equal to -5 ° C, or less than or equal to -10 ° C, or less than or equal to -20 ° C, or less than or equal to -25 ° C.
- it may be -20 °C to 45 °C.
- the stability may be maintained at -30 °C to 60 °C 4 weeks, at least 5 weeks, at least 6 weeks, at least 7 weeks, at least 8 weeks, or at least 9 weeks. Further, 10 weeks or less, 9 weeks or less, 8 weeks or less, 7 weeks or less, 6 weeks or less, or 5 weeks or less may be maintained.
- the hydrophobic visible light blocker may be dispersed by homogenizing for 1 to 20 minutes at 5000 to 15000rpm. Preferably, it may be dispersed by homogenizing for 3 to 8 minutes at 8000 to 12000 rpm. In one embodiment, the homogenization may be to homogenize in the water phase, or in the oil phase.
- the cosmetic composition may be obtained by homogeneously dispersing the hydrophobic visible light blocker and then emulsifying it with other raw materials or components. In one embodiment, the emulsification may be performed for 1 to 20 minutes at 5000 to 15000 rpm, and preferably for 3 to 6 minutes at 8000 to 12000 rpm.
- the cosmetic composition may be for improving skin tone while simultaneously blocking visible light.
- a hydrophobic visible light blocker eg, titanium dioxide surface-treated with a hydrophobic material
- harmful visible light eg, one or more of blue light and violet light
- the cosmetic composition may further include a functional additive and components included in the general cosmetic composition.
- the functional additive may include, for example, a component selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, sphingolipids, and seaweed extracts.
- oils and fats moisturizers, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavorings, blood circulation And accelerators, cooling agents, limiting agents, purified water, and the like.
- the cosmetic composition is not particularly limited in shape, and may be appropriately selected depending on the intended purpose.
- face wash, cleaning product, exfoliating product, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nourishing lotion, massage cream, nourishing cream, moisturizing cream, hand cream, foundation , Essence, nutrition essence, pack, soap, cleansing foam, cleansing gel, cleansing lotion, cleansing cream, body lotion and body cleanser may be prepared in any one or more forms selected from, but is not limited thereto. Preferably in the form of lotions or creams.
- the carrier component is animal fiber, vegetable fiber, wax, paraffin, starch, trakant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. And the like can be used.
- a solvent, solvating agent or emulsifying agent is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Fatty acid esters of propylene glycol, 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycols or sorbitan.
- an aliphatic alcohol sulfate an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethionate, an imidazolinium derivative, methyl taurate, and sarcosinate
- Fatty acid amide ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
- the present invention includes an oil phase including the sunscreen and silicone oil, at least one or more of the surfactants, and an aqueous phase including a thickener and a hydrophobic visible light blocker homogeneously dispersed in the aqueous phase. It may be to a method for blocking the visible light comprising the step of administering a cosmetic composition to the subject in need thereof.
- the present invention includes an oil phase including the sunscreen and silicone oil, at least one or more of the surfactants, and an aqueous phase including a thickener and a hydrophobic visible light blocker homogeneously dispersed in the aqueous phase. It may be directed to a method for improving visible light blocking and skin tone, comprising administering a cosmetic composition to a subject in need thereof.
- the present invention provides an oil phase part including the sunscreen agent and silicone oil, an aqueous phase part including at least one of the surfactant and a thickener, and an aqueous phase part, for preparing a cosmetic composition for blocking visible light. It may be directed to the use of a composition comprising a homogeneously dispersed hydrophobic light blocker.
- the present invention provides an oil-based part including the sunscreen agent and silicone oil, an aqueous phase including at least one of the surfactants, and a thickener for producing a cosmetic composition for blocking visible light and improving skin tone. It may be related to the use of the composition comprising a hydrophobic visible light blocker homogeneously dispersed in the water phase.
- the present invention provides an oil phase part including the sunscreen agent and silicone oil, at least one or more of the surfactants, and an aqueous phase part and the water phase part, for use in blocking visible light or improving skin tone. It may be directed to the use of a composition comprising a homogeneously dispersed hydrophobic light blocker.
- the present invention is directed to the use of a surfactant contained in a specific content as one or more selected from the group consisting of a phosphate surfactant, a glutamate surfactant, and a carbamate surfactant to enhance formulation stability of the cosmetic composition. It may be about.
- a cosmetic composition was prepared by dispersing TiO 2 for hydrophobic pigments (for coloring agents) in an aqueous phase of an O / W emulsion formulation using potassium cetylphosphate.
- O / W emulsion formulations are prepared using the ingredients in Table 1 below, but may be prepared using conventional methods for preparing O / W emulsion formulations.
- a sunscreen cosmetic composition comprising the ingredients listed in Table 1
- the components of the oil phase in the table was mixed according to the numerical value (% by weight) in the table and warmed to 75 (mixture 1).
- the aqueous phase components in the table were mixed according to the numerical values (% by weight) in the table and then warmed to 75 (mixture 2).
- composition was prepared according to the above method, but the content (% by weight) for the specific component was changed according to Table 1 below.
- composition according to the embodiment was measured whether the actual cosmetic composition and cosmetic preparation, formulation stability, UV blocking ability, harmful visible light (blue and violet) blocking effect, and investigated the presence of skin tone correction.
- Formulation stability is determined by using the above-described embodiment after the actual cosmetic composition (e.g., sunscreen product) at -20 degrees, 5 degrees, room temperature, 30 degrees, 45 degrees for 4 weeks, whether the powder agglomeration, appearance changes It confirmed as a result of observing whether or not.
- the actual cosmetic composition e.g., sunscreen product
- the UVB protection factor (SPF) was measured according to the UV protection effect measurement method and standard by the ISO test method (ISO 24444).
- 12 subjects suitable for the purpose of testing through medical history examination and skin condition diagnosis were irradiated with ultraviolet light using Multiport Solar UV Simulator (601-300W) on the unbacked area and after 16 ⁇ 24 hours Minimal Erythema Dose (MED) was determined.
- Samples of the cosmetic composition shown in Table 1 above were uniformly applied to the skin at a thickness of 2 mg / cm 2 , respectively. Based on the uncoated MED, ultraviolet light was irradiated to determine the MED and SPF of the standard and test composition samples.
- the UV blocking index (SPFi) for each subject was calculated and the UV blocking index of the composition sample was determined by an arithmetic mean value.
- UV protection index (SPFi) for each subject minimum amount of erythema at the product application site / minimum amount of erythema at the product-free area
- UVA protection dimension Protection Factor of UVA, PFA
- PFA Photo-Protection Factor of UVA
- the MPPD means the minimum sustained instant blackening amount (the minimum ultraviolet irradiation amount in which faint blackening is recognized) (“MPPD”).
- the formulations of Examples and Comparative Examples were applied in an amount of 2 mg / cm 2 on quartz or a band pass filter, respectively, and then blue light / violet
- the light source including the region was irradiated and the transmitted blue / violet light wavelength region (380-500 nm) was measured with an SPR-4001 spectroradiometer (Spectroradiometer, Luzchem, Canada).
- compositions except for Example 3 can be prepared with regard to whether they can be made into sunscreen cosmetics (eg sunscreen products) in cream formulations.
- sunscreen cosmetics eg sunscreen products
- the hydrophobic visible light blocker was stable in an effective and homogeneously dispersed state in the water phase. Emulsion formulation is maintained). It does not contain the potassium cetyl phosphate, a water-dispersible coloring TiO 2 for In the case of Example 2 containing TiO 2 coated with a hydrophilic (water dispersible) material appeared to aggregate, it was impossible to maintain the formulation.
- Example 3 which contained but did not contain potassium cetylphosphate, the hydrophobic visible light blocker (TiO 2 coated with a hydrophobic material) was not homogeneously dispersed in the water phase, so that emulsion stability was not maintained.
- Formulation stability, UV blocking effect and harmful visible light blocking effect according to the content of potassium cetylphosphate were measured.
- Experimental results of Experimental Examples 1 and 2 are considered to be similar when the composition is prepared using zinc oxide or iron oxide instead of titanium dioxide, and sodium stearoyl glutamate or inulin lauryl carbamate may be used instead of potassium cetylphosphate. It was confirmed that the case came out similarly.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11201907890UA SG11201907890UA (en) | 2017-02-27 | 2018-02-26 | Cosmetic composition for filtering blue light and blocking ultraviolet ray |
CN201880023294.6A CN110494115B (zh) | 2017-02-27 | 2018-02-26 | 用于过滤蓝光与阻隔紫外光的化妆品组合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170025307A KR102672901B1 (ko) | 2017-02-27 | 2017-02-27 | 유해 광선 차단 화장료 조성물 |
KR10-2017-0025307 | 2017-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018155974A1 true WO2018155974A1 (ko) | 2018-08-30 |
Family
ID=63253843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/002319 WO2018155974A1 (ko) | 2017-02-27 | 2018-02-26 | 블루라이트 필터링 및 자외선 차단 화장료 조성물 |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR102672901B1 (zh) |
CN (1) | CN110494115B (zh) |
SG (1) | SG11201907890UA (zh) |
TW (1) | TWI771377B (zh) |
WO (1) | WO2018155974A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102214051B1 (ko) * | 2018-10-29 | 2021-02-09 | 코스맥스 주식회사 | 블루라이트 차단용 무기 입자를 포함하는 화장료 조성물 |
KR102168166B1 (ko) * | 2018-11-08 | 2020-10-21 | 주식회사 코리아나화장품 | 블루라이트 차단용 화장료 조성물 |
WO2020149430A1 (ko) * | 2019-01-16 | 2020-07-23 | 코스맥스 주식회사 | 내수성을 갖는 수중유형 자외선 차단용 화장료 조성물 |
KR102268228B1 (ko) * | 2019-05-20 | 2021-06-24 | 코스맥스 주식회사 | 자외선 차단용 화장료 조성물 |
CN114173756A (zh) * | 2019-07-25 | 2022-03-11 | 三好化成株式会社 | 亲水化无机粉末和掺混有该亲水化无机粉末的化妆品 |
KR102298142B1 (ko) * | 2019-10-29 | 2021-09-06 | 코스맥스 주식회사 | 티타늄디옥사이드가 이중 분산된 수중유형 자외선 차단용 화장료 조성물 |
CN113116736A (zh) * | 2019-12-31 | 2021-07-16 | 新生活化妆品科技(上海)有限公司 | 一种无机复合粉体及制备方法、应用与化妆材料组合物 |
KR102362336B1 (ko) * | 2020-06-01 | 2022-02-14 | 주식회사 초이스엔텍 | 자외선, 근적외선 및 블루라이트 차단용 징크옥사이드 유분산액 및 이를 포함하는 화장료 조성물 |
KR102176704B1 (ko) * | 2020-06-08 | 2020-11-09 | 한국콜마주식회사 | 무기 점증제 및 유기 점증제를 포함하는 수분산 제형의 자외선 차단용 화장료 조성물 |
KR102574547B1 (ko) * | 2020-10-28 | 2023-09-12 | 코스맥스 주식회사 | 무기분체를 안정적으로 내포하는 워터 드롭 매크로 에멀젼 화장료 조성물 및 이의 제조방법 |
KR102532227B1 (ko) * | 2020-11-03 | 2023-05-15 | 아이큐어 주식회사 | 자외선 및 블루라이트 차단용 유무기 복합소재 및 그 제조방법 |
KR102534801B1 (ko) * | 2020-11-03 | 2023-05-19 | 아이큐어 주식회사 | 자외선 및 블루라이트 차단용 화장료 조성물 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0619999A2 (en) * | 1993-04-14 | 1994-10-19 | Tioxide Specialties Limited | Compositions containing sunscreens |
KR100321188B1 (ko) * | 1996-09-27 | 2002-01-19 | 데이비드 엠 모이어 | 안정한 차광 조성물 |
KR20040095267A (ko) * | 2002-03-06 | 2004-11-12 | 다우 글로벌 테크놀로지스 인크. | 화장품 제형의 제조방법 및 이를 위한 조성물 |
US20060280702A1 (en) * | 2005-06-10 | 2006-12-14 | Amcol International Corporation | Stable sunscreen compositions containing zinc oxide |
WO2016173927A1 (en) * | 2015-04-29 | 2016-11-03 | Dsm Ip Assets B.V. | Topical sunscreen emulsions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS501267B1 (zh) * | 1970-12-28 | 1975-01-16 | ||
KR20100022010A (ko) * | 2007-04-26 | 2010-02-26 | 가부시키가이샤 시세이도 | 수중유형 유화 조성물과 그 제조 방법 |
EP2320865B1 (en) * | 2008-07-16 | 2012-07-04 | DSM IP Assets B.V. | Use of pentasodium (ethylenediamine)tetramethylenephosphate for suppressing discoloration in topical compositions |
ES2559236T3 (es) * | 2009-07-24 | 2016-02-11 | Coreana Cosmetics Co., Ltd. | Polvo de compuesto para bloquear simultáneamente rayos ultravioleta e infrarrojo y composición cosmética que utiliza lo mismo |
EP2982363A1 (en) * | 2014-08-04 | 2016-02-10 | Omya International AG | Two component system for cosmetic formulations |
-
2017
- 2017-02-27 KR KR1020170025307A patent/KR102672901B1/ko active Active
-
2018
- 2018-02-26 TW TW107106333A patent/TWI771377B/zh active
- 2018-02-26 CN CN201880023294.6A patent/CN110494115B/zh active Active
- 2018-02-26 SG SG11201907890UA patent/SG11201907890UA/en unknown
- 2018-02-26 WO PCT/KR2018/002319 patent/WO2018155974A1/ko active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0619999A2 (en) * | 1993-04-14 | 1994-10-19 | Tioxide Specialties Limited | Compositions containing sunscreens |
KR100321188B1 (ko) * | 1996-09-27 | 2002-01-19 | 데이비드 엠 모이어 | 안정한 차광 조성물 |
KR20040095267A (ko) * | 2002-03-06 | 2004-11-12 | 다우 글로벌 테크놀로지스 인크. | 화장품 제형의 제조방법 및 이를 위한 조성물 |
US20060280702A1 (en) * | 2005-06-10 | 2006-12-14 | Amcol International Corporation | Stable sunscreen compositions containing zinc oxide |
WO2016173927A1 (en) * | 2015-04-29 | 2016-11-03 | Dsm Ip Assets B.V. | Topical sunscreen emulsions |
Also Published As
Publication number | Publication date |
---|---|
KR20180098773A (ko) | 2018-09-05 |
CN110494115A (zh) | 2019-11-22 |
TW201838685A (zh) | 2018-11-01 |
TWI771377B (zh) | 2022-07-21 |
KR102672901B1 (ko) | 2024-06-10 |
SG11201907890UA (en) | 2019-09-27 |
CN110494115B (zh) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018155974A1 (ko) | 블루라이트 필터링 및 자외선 차단 화장료 조성물 | |
JP2954068B2 (ja) | 微小顔料を含有する化粧品組成物 | |
EP2174639B1 (en) | Body cosmetics for wetted skin | |
WO2011010798A2 (ko) | 적외선 및 자외선 동시차단용 복합분체 및 그를 이용한 화장료 조성물 | |
CN104546512A (zh) | 硅橡胶颗粒的水分散液、硅橡胶颗粒、以及化妆品 | |
JPH0840825A (ja) | 中空の熱可塑性粒子で安定化した界面活性剤フリーの水中油型エマルション | |
JP7152161B2 (ja) | 皮膚外用剤又は化粧料 | |
CN110114053A (zh) | 水包油型乳化组合物 | |
US9226881B2 (en) | Multi-functional composite powder | |
EP3360537B1 (en) | Oil-in-water type organopolysiloxane emulsion and method for producing same, cosmetic raw material, and cosmetic product | |
KR20160110125A (ko) | 겔 페이스트 조성물 및 이 겔 페이스트 조성물을 이용한 화장료 | |
US20140335136A1 (en) | Compositions for minimizing skin imperfections | |
JP7309373B2 (ja) | 油中水型乳化組成物 | |
KR20080081925A (ko) | 미립자 산화티탄 분산물과 이를 포함하는 화장료 | |
KR102498844B1 (ko) | 무기자외선차단제 고함유 자외선차단 화장료 조성물 | |
JP2001278729A (ja) | 油中水型乳化組成物 | |
WO2018052260A1 (ko) | 화산송이 분말을 포함하는 메이크업 화장료 조성물 | |
CN104136503A (zh) | 复合有机硅粉末的水性悬浮液、w/o乳液和化妆品 | |
BR112014027027B1 (pt) | composição cosmética, método cosmético para clarear e uso de uma combinação | |
JPH069359A (ja) | 紫外線遮断性粉体 | |
AU2015277745A1 (en) | Compositions and methods for enhancing the topical application of a color cosmetic | |
JP2024103074A (ja) | 水中油型日焼け止め化粧料 | |
JP2002265342A (ja) | 紫外線防御化粧料 | |
JP7313860B2 (ja) | 水中油型乳化化粧料 | |
KR100667048B1 (ko) | 국부 피부보호 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18758212 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18758212 Country of ref document: EP Kind code of ref document: A1 |